Gene Delivery to Chondrocytes.
Cartilage
Chondrocyte
Gene therapy
Osteoarthritis
Journal
Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
17
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
ppublish
Résumé
Delivering genes to chondrocytes offers new possibilities both clinically, for treating conditions that affect cartilage, and in the laboratory, for studying the biology of chondrocytes. Advances in gene therapy have created a number of different viral and non-viral vectors for this purpose. These vectors may be deployed in an ex vivo fashion, where chondrocytes are genetically modified outside the body, or by in vivo delivery where the vector is introduced directly into the body; in the case of articular and meniscal cartilage in vivo delivery is typically by intra-articular injection. Ex vivo delivery is favored in strategies for enhancing cartilage repair as these can be piggy-backed on existing cell-based technologies, such as autologous chondrocyte implantation, or used in conjunction with marrow-stimulating techniques such as microfracture. In vivo delivery to articular chondrocytes has proved more difficult, because the dense, anionic, extra-cellular matrix of cartilage limits access to the chondrocytes embedded within it. As Grodzinsky and colleagues have shown, the matrix imposes strict limits on the size and charge of particles able to diffuse through the entire depth of articular cartilage. Empirical observations suggest that the larger viral vectors, such as adenovirus (~100 nm), are unable to transduce chondrocytes in situ following intra-articular injection. However, adeno-associated virus (AAV; ~25 nm) is able to do so in horse joints. AAV is presently in clinical trials for arthritis gene therapy, and it will be interesting to see whether human chondrocytes are also transduced throughout the depth of cartilage by AAV following a single intra-articular injection. Viral vectors have been used to deliver genes to the intervertebral disk but there has been little research on gene transfer to chondrocytes in other cartilaginous tissues such as nasal, auricular or tracheal cartilage.
Identifiants
pubmed: 37052849
doi: 10.1007/978-3-031-25588-5_7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
95-105Informations de copyright
© 2023. The Author(s).
Références
Evans CH, Ghivizzani SC, Robbins PD (2021) Orthopaedic gene therapy: twenty-five years on. JBJS Rev 9. https://doi.org/10.2106/JBJS.RVW.20.00220
Ghivizzani SC, Watson-Levings RS, Palmer GD, Levings PP, Dacanay AE, Evans CH (2022) Gene therapy in orthopaedics: progress and challenges in pre-clinical development and translation. Front Bioeng Biotechnol 10:901317
pubmed: 35837555
pmcid: 9274665
doi: 10.3389/fbioe.2022.901317
Nagelli CV, Evans CH, de la Vega, RE (2023) Viral gene delivery in chondrocytes. In: Stoddart MJ, Della Bella E, Armiento AR (eds) Cartilage tissue engineering. Methods in molecular biology, vol 2598. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2839-3_20
Lundstrom K (2018) Viral vectors in gene therapy. Diseases 6:42
pubmed: 29883422
pmcid: 6023384
doi: 10.3390/diseases6020042
Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419
pubmed: 14564000
doi: 10.1126/science.1088547
George LA, Monahan PE, Eyster ME, Sullivan SK, Ragni MV, Croteau SE, Rasko JEJ, Recht M, Samelson-Jones BJ, MacDougall A, Jaworski K, Noble R, Curran M, Kuranda K, Mingozzi F, Chang T, Reape KZ, Anguela XM, High KA (2021) Multiyear factor VIII expression after AAV gene transfer for Hemophilia A. N Engl J Med 385:1961–1973
pubmed: 34788507
pmcid: 8672712
doi: 10.1056/NEJMoa2104205
Kreiss P, Cameron B, Rangara R, Mailhe P, Aguerre-Charriol O, Airiau M, Scherman D, Crouzet J, Pitard B (1999) Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res 27:3792–3798
pubmed: 10481017
pmcid: 148641
doi: 10.1093/nar/27.19.3792
Yin W, Xiang P, Li Q (2005) Investigations of the effect of DNA size in transient transfection assay using dual luciferase system. Anal Biochem 346:289–294
pubmed: 16213455
doi: 10.1016/j.ab.2005.08.029
Zu H, Gao D (2021) Non-viral vectors in gene therapy: recent development, challenges, and prospects. AAPS J 23:78
pubmed: 34076797
doi: 10.1208/s12248-021-00608-7
Slivac I, Guay D, Mangion M, Champeil J, Gaillet B (2017) Non-viral nucleic acid delivery methods. Expert Opin Biol Ther 17:105–118
pubmed: 27740858
doi: 10.1080/14712598.2017.1248941
Damase TR, Sukhovershin R, Boada C, Taraballi F, Pettigrew RI, Cooke JP (2021) The limitless future of RNA therapeutics. Front Bioeng Biotechnol 9:628137
pubmed: 33816449
pmcid: 8012680
doi: 10.3389/fbioe.2021.628137
De La Vega RE, van Griensven M, Zhang W, Coenen MJ, Nagelli CV, Panos JA, Peniche Silva CJ, Geiger J, Plank C, Evans CH, Balmayor ER (2022) Efficient healing of large osseous segmental defects using optimized chemically modified messenger RNA encoding BMP-2. Sci Adv 8:eabl6242
pubmed: 35171668
doi: 10.1126/sciadv.abl6242
Bonadio J, Smiley E, Patil P, Goldstein S (1999) Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5:753–759
pubmed: 10395319
doi: 10.1038/10473
Raisin S, Belamie E, Morille M (2016) Non-viral gene activated matrices for mesenchymal stem cells based tissue engineering of bone and cartilage. Biomaterials 104:223–237
pubmed: 27467418
doi: 10.1016/j.biomaterials.2016.07.017
Cam C, Segura T (2013) Matrix-based gene delivery for tissue repair. Curr Opin Biotechnol 24:855–863
pubmed: 23680305
pmcid: 3770770
doi: 10.1016/j.copbio.2013.04.007
Kang R, Marui T, Ghivizzani SC, Nita IM, Georgescu HI, Suh JK, Robbins PD, Evans CH (1997) Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarthr Cartil 5:139–143
doi: 10.1016/S1063-4584(97)80007-6
Baragi VM, Renkiewicz RR, Jordan H, Bonadio J, Hartman JW, Roessler BJ (1995) Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J Clin Invest 96:2454–2460
pubmed: 7593634
pmcid: 185898
doi: 10.1172/JCI118303
Palmer GD, Gouze E, Gouze JN, Betz OB, Evans CH, Ghivizzani SC (2003) Gene transfer to articular chondrocytes with recombinant adenovirus. Methods Mol Biol 215:235–246
pubmed: 12512303
Evans CH, Kraus VB, Setton LA (2014) Progress in intra-articular therapy. Nat Rev Rheumatol 10:11–22
pubmed: 24189839
doi: 10.1038/nrrheum.2013.159
Evans CH (2018) Catering to chondrocytes. Sci Transl Med 10:eaav7043
pubmed: 30487250
doi: 10.1126/scitranslmed.aav7043
Krishnan Y, Rees HA, Rossitto CP, Kim SE, Hung HK, Frank EH, Olsen BD, Liu DR, Hammond PT, Grodzinsky AJ (2018) Green fluorescent proteins engineered for cartilage-targeted drug delivery: insights for transport into highly charged avascular tissues. Biomaterials 183:218–233
pubmed: 30173104
pmcid: 6141342
doi: 10.1016/j.biomaterials.2018.08.050
Bajpayee AG, Wong CR, Bawendi MG, Frank EH, Grodzinsky AJ (2014) Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis. Biomaterials 35:538–549
pubmed: 24120044
doi: 10.1016/j.biomaterials.2013.09.091
Bajpayee AG, Grodzinsky AJ (2017) Cartilage-targeting drug delivery: can electrostatic interactions help? Nat Rev Rheumatol 13:183–193
pubmed: 28202920
doi: 10.1038/nrrheum.2016.210
Baragi VM, Renkiewicz RR, Qiu L, Brammer D, Riley JM, Sigler RE, Frenkel SR, Amin A, Abramson SB, Roessler BJ (1997) Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. Osteoarthr Cartil 5:275–282
doi: 10.1016/S1063-4584(97)80023-4
ter Huurne M, Schelbergen R, Blattes R, Blom A, de Munter W, Grevers LC, Jeanson J, Noel D, Casteilla L, Jorgensen C, van den Berg W, van Lent PL (2012) Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum 64:3604–3613
pubmed: 22961401
doi: 10.1002/art.34626
Horie M, Choi H, Lee RH, Reger RL, Ylostalo J, Muneta T, Sekiya I, Prockop DJ (2012) Intra-articular injection of human mesenchymal stem cells (MSCs) promote rat meniscal regeneration by being activated to express Indian hedgehog that enhances expression of type II collagen. Osteoarthr Cartil 20:1197–1207
doi: 10.1016/j.joca.2012.06.002
Ozeki N, Muneta T, Koga H, Nakagawa Y, Mizuno M, Tsuji K, Mabuchi Y, Akazawa C, Kobayashi E, Matsumoto K, Futamura K, Saito T, Sekiya I (2016) Not single but periodic injections of synovial mesenchymal stem cells maintain viable cells in knees and inhibit osteoarthritis progression in rats. Osteoarthr Cartil 24:1061–1070
doi: 10.1016/j.joca.2015.12.018
Cucchiarini M, Madry H (2019) Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair. Nat Rev Rheumatol 15:18–29
pubmed: 30514957
doi: 10.1038/s41584-018-0125-2
Watson Levings RS, Broome TA, Smith AD, Rice BL, Gibbs EP, Myara DA, Hyddmark EV, Nasri E, Zarezadeh A, Levings PP, Lu Y, White ME, Dacanay EA, Foremny GB, Evans CH, Morton AJ, Winter M, Dark MJ, Nickerson DM, Colahan PT, Ghivizzani SC (2018) Gene therapy for osteoarthritis: pharmacokinetics of intra-articular self-complementary adeno-associated virus Interleukin-1 receptor antagonist delivery in an equine model, vol 29. Hum Gene Ther Clin Dev, pp 90–100
Bajpayee AG, Scheu M, Grodzinsky AJ, Porter RM (2015) A rabbit model demonstrates the influence of cartilage thickness on intra-articular drug delivery and retention within cartilage. J Orthop Res 33:660–667
pubmed: 25627105
doi: 10.1002/jor.22841
Evans CH, Robbins PD, Ghivizzani SC, Wasko MC, Tomaino MM, Kang R, Muzzonigro TA, Vogt M, Elder EM, Whiteside TL, Watkins SC, Herndon JH (2005) Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Natl Acad Sci U S A 102:8698–8703
pubmed: 15939878
pmcid: 1150836
doi: 10.1073/pnas.0502854102
Ha CW, Noh MJ, Choi KB, Lee KH (2012) Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients. Cytotherapy 14:247–256
pubmed: 22242865
pmcid: 3793276
doi: 10.3109/14653249.2011.629645
Evans CH, Ghivizzani SC, Robbins PD (2018) Arthritis gene therapy is becoming a reality. Nat Rev Rheumatol 14:381–382
pubmed: 29743627
doi: 10.1038/s41584-018-0009-5
Evans CH (2019) The vicissitudes of gene therapy. Bone Joint Res 8:469–471
pubmed: 31728185
pmcid: 6825047
doi: 10.1302/2046-3758.810.BJR-2019-0265
Goossens PH, Huizinga TW (2002) Adenoviral-mediated gene transfer to the synovial tissue. Clin Exp Rheumatol 20:415–419
pubmed: 12102483
Graceffa V, Vinatier C, Guicheux J, Evans CH, Stoddart M, Alini M, Zeugolis DI (2018) State of art and limitations in genetic engineering to induce stable chondrogenic phenotype. Biotechnol Adv 36:1855–1869
pubmed: 30012541
doi: 10.1016/j.biotechadv.2018.07.004
Palmer G, Pascher A, Gouze E, Gouze JN, Betz O, Spector M, Robbins PD, Evans CH, Ghivizzani SC (2002) Development of gene-based therapies for cartilage repair. Crit Rev Eukaryot Gene Expr 12:259–273
pubmed: 12641395
doi: 10.1615/CritRevEukaryotGeneExpr.v12.i4.20
Goodrich LR, Hidaka C, Robbins PD, Evans CH, Nixon AJ (2007) Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br 89:672–685
pubmed: 17540757
doi: 10.1302/0301-620X.89B5.18343
Hidaka C, Goodrich LR, Chen CT, Warren RF, Crystal RG, Nixon AJ (2003) Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J Orthop Res 21:573–583
pubmed: 12798054
doi: 10.1016/S0736-0266(02)00264-4
Ortved KF, Begum L, Mohammed HO, Nixon AJ (2015) Implantation of rAAV5-IGF-I transduced autologous chondrocytes improves cartilage repair in full-thickness defects in the equine model. Mol Ther 23:363–373
pubmed: 25311491
doi: 10.1038/mt.2014.198
Pascher A, Palmer GD, Steinert A, Oligino T, Gouze E, Gouze JN, Betz O, Spector M, Robbins PD, Evans CH, Ghivizzani SC (2004) Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther 11:133–141
pubmed: 14712297
doi: 10.1038/sj.gt.3302155
Palmer GD, Steinert A, Pascher A, Gouze E, Gouze JN, Betz O, Johnstone B, Evans CH, Ghivizzani SC (2005) Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol Ther 12:219–228
pubmed: 16043093
doi: 10.1016/j.ymthe.2005.03.024
Steinert AF, Palmer GD, Pilapil C, Noth U, Evans CH, Ghivizzani SC (2009) Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer. Tissue Eng Part A 15:1127–1139
pubmed: 18826340
doi: 10.1089/ten.tea.2007.0252
Sieker JT, Kunz M, Weissenberger M, Gilbert F, Frey S, Rudert M, Steinert AF (2015) Direct bone morphogenetic protein 2 and Indian hedgehog gene transfer for articular cartilage repair using bone marrow coagulates. Osteoarthr Cartil 23:433–442
doi: 10.1016/j.joca.2014.11.008
Nagelli CV, De La Vega RE, Coenen M, De Padilla CL, Panos JA, Tovar A, Müller SA, Evans CH (2022) Expedited gene delivery for osteochondral defect repair in a rabbit knee model: a one-year investigation. Osteoarthr Cartil Open 4:100257
pubmed: 36338933
pmcid: 9635382
doi: 10.1016/j.ocarto.2022.100257
Ivkovic A, Pascher A, Hudetz D, Maticic D, Jelic M, Dickinson S, Loparic M, Haspl M, Windhager R, Pecina M (2010) Articular cartilage repair by genetically modified bone marrow aspirate in sheep. Gene Ther 17:779–789
pubmed: 20220780
doi: 10.1038/gt.2010.16
Cucchiarini M, Asen AK, Goebel L, Venkatesan JK, Schmitt G, Zurakowski D, Menger MD, Laschke MW, Madry H (2018) Effects of TGF-beta overexpression via rAAV gene transfer on the early repair processes in an osteochondral defect model in minipigs. Am J Sports Med 46:1987–1996
pubmed: 29792508
doi: 10.1177/0363546518773709
Cucchiarini M, Madry H (2014) Overexpression of human IGF-I via direct rAAV-mediated gene transfer improves the early repair of articular cartilage defects in vivo. Gene Ther 21:811–819
pubmed: 24989812
doi: 10.1038/gt.2014.58
Cucchiarini M, Orth P, Madry H (2013) Direct rAAV SOX9 administration for durable articular cartilage repair with delayed terminal differentiation and hypertrophy in vivo. J Mol Med (Berl) 91:625–636
pubmed: 23149825
doi: 10.1007/s00109-012-0978-9
Lange C, Madry H, Venkatesan JK, Schmitt G, Speicher-Mentges S, Zurakowski D, Menger MD, Laschke MW, Cucchiarini M (2021) rAAV-mediated sox9 overexpression improves the repair of osteochondral defects in a clinically relevant large animal model over time in vivo and reduces perifocal osteoarthritic changes. Am J Sports Med 49:3696–3707
pubmed: 34643471
doi: 10.1177/03635465211049414
Morscheid YP, Venkatesan JK, Schmitt G, Orth P, Zurakowski D, Speicher-Mentges S, Menger MD, Laschke MW, Cucchiarini M, Madry H (2021) rAAV-mediated human FGF-2 gene therapy enhances osteochondral repair in a clinically relevant large animal model over time in vivo. Am J Sports Med 49:958–969
pubmed: 33606561
doi: 10.1177/0363546521988941
Madry H, Venkatesan JK, Carballo-Pedrares N, Rey-Rico A, Cucchiarini M (2020) Scaffold-mediated gene delivery for osteochondral repair. Pharmaceutics 12:930
pubmed: 33003607
pmcid: 7601511
doi: 10.3390/pharmaceutics12100930
Nishida K, Kang JD, Suh JK, Robbins PD, Evans CH, Gilbertson LG (1998) Adenovirus-mediated gene transfer to nucleus pulposus cells. Implications for the treatment of intervertebral disc degeneration. Spine (Phila Pa 1976) 23:2437–2442. discussion 2443
pubmed: 9836359
doi: 10.1097/00007632-199811150-00016